Regadenoson Induces Comparable Left Ventricular Perfusion Defects as Adenosine
John J. Mahmarian(Houston Methodist), Ann Olmsted(Carolina Veterinary Specialists), Manuel D. Cerqueira(Cleveland Clinic), Lemuel A. Moyé(University of Houston), Ami E. Iskandrian(University of Alabama at Birmingham), Robert C. Hendel, Timothy M. Bateman(University of Missouri–Kansas City), Gregory S. Thomas(Orange Coast Memorial Medical Center)
Cited by 132
Related Papers
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients
|The Lancet|2000|1.6k
Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes
|JAMA|2009|817
Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects
|Diabetes Care|2004|789
AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update
|Journal of the American College of Cardiology|2001|691